The first 90 days on GLP1 medications: what many people experience

The first injection is almost always quieter than people expect. A small click, a brief sting, a moment of waiting for something dramatic to happen. Nothing does. The pen goes back in the drawer. The day continues as before. It is only over the next several weeks — sometimes the next several days — that the body slowly begins to behave like a slightly different version of itself.

The first ninety days on a GLP1 medication are the chapter that sets the tone for everything that comes after. Side effects, if they appear, appear in this window. Appetite finds its new baseline. The scale begins to move, then stops, then moves again. Energy dips and lifts. The mind quietly rearranges its relationship with food. By the end of three months, most users have a much clearer sense of what the rest of the journey will feel like.

This is a realistic, week-by-week look at what many people on Wegovy, Ozempic, Mounjaro, or Zepbound describe across that period. It is not a promise. Bodies vary, doses vary, lives vary. But the broad pattern is consistent enough that having it on hand makes the journey calmer than it otherwise would be.

The quick answer

Week one: surprisingly little, and that is normal

The first dose is usually the lowest dose, designed to introduce the body to the medication gently. Most users feel almost nothing in the first three or four days. A few report mild queasiness, a slightly earlier feeling of fullness at meals, or a subtle quieting of food thoughts. The scale does not yet move in any meaningful way. Energy is roughly normal. Sleep is roughly normal.

By day five or six, more people begin to notice the early appetite changes. Meals that used to be finished are left half-eaten without effort. The afternoon snack feels less necessary. Many users describe a slightly drier mouth and a need to drink more water than they expected. Some experience a mild headache, often related to the early shift in hydration and electrolytes.

The week ends, for most, with the recognition that something is happening, but very little drama. This is the medication doing its quiet introduction.

Weeks two to four: the body finds its baseline

The second week is often where appetite changes become unmistakable. Portions shrink visibly. Cravings for ultra-processed foods soften. The cupboard is opened less. Some users notice a quiet shift in mood — calmer, less reactive — that they cannot yet attribute to anything specific. Others notice nothing at all and start wondering whether the medication is working.

Side effects, when they appear, tend to do so in this window. Mild nausea after meals is by far the most common. Constipation, often more bothersome than the nausea, is a close second. Reflux can appear for the first time. A small group experience mild dizziness, particularly on standing, usually related to dehydration. Most of these are manageable with the small adjustments the body has been asking for all along: more water, more protein, smaller meals, eating slowly, salting food a little more generously.

The scale typically begins to move in week three or four, often more in the form of fluid loss than anything dramatic. A drop of two to four pounds is common; a drop of more is not unusual. Most users find themselves checking the scale more often than they should and reacting more emotionally than they meant to. This is normal. It is also the moment to set up a calmer weekly tracking rhythm before daily weighing becomes a habit.

Why daily weighing is misleading on a GLP1 →

Weeks four to six: the first real momentum

By week four, most users have settled into a recognisable pattern. Smaller meals feel normal. Hunger arrives, when it arrives, more politely. Cravings are quieter. The first dose increase is often scheduled here, depending on the medication and the prescriber, and tends to bring a brief return of mild nausea for a few days before the body adjusts again.

The scale, in this window, often produces the first visibly significant change. A loss of four to ten pounds over the first six weeks is well within the typical range, with significant variation between bodies. Clothes begin to fit differently, particularly around the waist and face. Users start to receive the first comments from people who do not know they are on the medication, and most describe a quiet, complicated mix of pleasure and self-consciousness.

Energy, in this window, is more variable. Some users feel lighter and clearer; others experience the low-grade fatigue described in our companion article on tiredness. The most important fix in either case is the same: enough food, enough water, enough protein, enough sleep.

Why some people feel tired on GLP1 medications →

Weeks six to eight: the first plateau is almost guaranteed

Almost everyone experiences a stretch in this window where the scale appears to stall. After several weeks of relatively steady loss, a few days, sometimes a few weeks, go by with little to no apparent movement. The temptation is to panic, cut calories further, or assume the medication has stopped working.

Almost none of these reactions are helpful. Plateaus in the first months are usually a combination of natural water shifts, the body adapting to its new energy intake, and the slow rebuilding of glycogen stores as eating patterns settle. Body composition is often continuing to improve underneath. Most users find that, if they hold their habits steady and resist the urge to over-correct, the scale catches up within one to three weeks with a sudden drop.

This is also the window in which sleep, hydration, and protein become the most influential variables. Users who treat the plateau as a signal to tighten up these fundamentals almost always come out the other side. Users who tighten the calorie deficit further almost always pay for it in fatigue and mood, with little extra weight loss to show.

Month three: a new normal begins to settle

By the end of month three, the medication has stopped feeling like a new presence in the day and started feeling like part of how the body now operates. Meals are smaller and quieter. Snacking is rare or thoughtful. The injection has become routine. Side effects, if they were present, have usually eased into something occasional and manageable. The relationship with food has shifted in ways that, three months earlier, would have been hard to imagine.

The total weight loss over ninety days varies considerably. A common range is six to fifteen percent of starting body weight, with some users below and some above. More important than the precise number is the trend: a clear downward direction, with the expected fluctuations and plateaus, and a body that feels different in a recognisable way.

By this point, most users also know which side effects they personally are prone to, which foods they tolerate well, which times of day they feel best, and what kind of weekly rhythm works for their life. This is the most valuable piece of the first ninety days — not the weight loss, but the self-knowledge that the rest of the journey will be built on.

What most users wish they had known on day one

• Eat enough protein from the first week — not the third month.
• Drink more water than feels necessary, on a schedule, from the start.
• Weigh once or twice a week, not daily, and look at the trend over four weeks.
• Salt food a little more generously, particularly in the first month.
• Expect a plateau around week six and do not panic when it arrives.
• The day after the injection is often the heaviest — plan accordingly.
• Resistance training matters more than cardio on a GLP1.
• Sleep is one of the most underrated variables in the entire experience.
• The emotional adjustment is real — give it the same respect as the physical one.

Why tracking from day one pays off later

The single most useful habit in the first ninety days is the calm logging of a handful of small signals — weight once or twice a week, appetite, hydration, sleep, mood, symptoms, injection day, protein intake. None of these take more than a few seconds. Together, over weeks, they make the patterns of the body's response visible in a way that memory alone never quite manages.

Users who track from the beginning have a far easier time understanding their plateaus, their dose increases, their good and bad weeks. They make better decisions, panic less often, and arrive at month three with a much clearer map of their own body's response. The journey gets easier the longer this habit runs.

Start your weekly check-ins →

What tends to happen after the first 90 days

Beyond the three-month mark, the journey usually becomes more stable and less dramatic. Weight loss continues, often at a slower pace. Side effects ease further. The relationship with food settles into a new normal. Dose adjustments may continue depending on the medication and the prescriber's plan, with each step often producing a brief return of mild side effects before the body adapts.

The work in the next chapter is less about adjustment and more about consistency — protecting muscle, eating well on a small appetite, sleeping properly, maintaining hydration, and continuing the quiet weekly tracking that makes the journey legible. The first ninety days teach the body how to do this. The years that follow turn it into a habit.

Final reflection

The first ninety days on a GLP1 medication are not, for most people, the most dramatic chapter. They are the most formative. The patterns that emerge in this window — how the body responds to dose changes, which foods work, how energy shifts across the week, how the mind handles the slow shift in self-image — are the patterns that the rest of the journey will be built on.

Users who pass through these three months with calm attention, who treat the small signals seriously, and who resist the urge to read every fluctuation as a verdict, usually find that the rest of the experience is easier, quieter, and more sustainable than they expected. The first ninety days are mostly about learning. Everything after is mostly about staying close to what was learned.

Track your journey with GLP1 Journal →